Effectiveness of Telephone Counselling by a Pharmacist in Reducing Mortality in Patients Receiving Polypharmacy: Randomised Controlled Trial

Overview

Journal BMJ

Specialty General Medicine

Date 2006 Aug 19

PMID 16916809

Citations 76

Authors

Jennifer Y F Wu

Wilson Y S Leung

Sophie Chang

Benjamin Lee

Benny Zee

Peter C Y Tong

Juliana C N Chan

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effects of compliance and periodic telephone counselling by a pharmacist on mortality in patients receiving polypharmacy.

Design: Two year randomised controlled trial.

Setting: Hospital medical clinic.

Participants: 502 of 1011 patients receiving five or more drugs for chronic disease found to be non-compliant at the screening visit were invited for randomisation to either the telephone counselling group (n = 219) or control group (n = 223) at enrollment 12-16 weeks later.

Main Outcome Measures: Primary outcome was all cause mortality in randomised patients. Associations between compliance and mortality in the entire cohort of 1011 patients were also examined. Patients were defined as compliant with a drug if they took 80-120% of the prescribed daily dose. To calculate a compliance score for the whole treatment regimen, the number of drugs that the patient was fully compliant with was divided by the total number of prescribed drugs and expressed as a percentage. Only patients who complied with all recommended drugs were considered compliant (100% score).

Results: 60 of the 502 eligible patients defaulted and only 442 patients were randomised. After two years, 31 (52%) of the defaulters had died, 38 (17%) of the control group had died, and 25 (11%) of the intervention group had died. After adjustment for confounders, telephone counselling was associated with a 41% reduction in the risk of death (relative risk 0.59, 95% confidence interval 0.35 to 0.97; P = 0.039). The number needed to treat to prevent one death at two years was 16. Other predictors included old age, living alone, rate of admission to hospital, compliance score, number of drugs for chronic disease, and non-treatment with lipid lowering drugs at screening visit. In the cohort of 1011 patients, the adjusted relative risk for death was 1.61 (1.05 to 2.48; P = 0.029) and 2.87 (1.80 to 2.57; P < 0.001) in patients with compliance scores of 34-66% and 0-33%, respectively, compared with those who had a compliance score of 67% or more.

Conclusion: In patients receiving polypharmacy, poor compliance was associated with increased mortality. Periodic telephone counselling by a pharmacist improved compliance and reduced mortality.

Trial Registration: International Standard Randomised Controlled Trial Number Register: SRCTN48076318.

Citing Articles

Strategies to Improve Therapeutic Adherence in Polymedicated Patients over 65 Years: A Systematic Review and Meta-Analysis.

Burgos-Alonso N, Torrecilla M, Mendiguren A, Perez-Gomez Moreta M, Bruzos-Cidon C Pharmacy (Basel). 2024; 12(1).

PMID: 38392942 PMC: 10892390. DOI: 10.3390/pharmacy12010035.

Nature and perceived benefits of patient-initiated consultations in community pharmacies: A population survey.

Pare G, Motulsky A, Castonguay A, Boulenger S Explor Res Clin Soc Pharm. 2022; 8:100194.

PMID: 36311824 PMC: 9615028. DOI: 10.1016/j.rcsop.2022.100194.

Factors affecting medication adherence among older adults using tele-pharmacy services: a scoping review.

Emadi F, Ghanbarzadegan A, Ghahramani S, Bastani P, Baysari M Arch Public Health. 2022; 80(1):199.

PMID: 36042508 PMC: 9429665. DOI: 10.1186/s13690-022-00960-w.

Harrison M, Marfo A, Buabeng K, Nkansah F, Boateng D, Ankrah D Health Sci Rep. 2022; 5(5):e786.

PMID: 36032513 PMC: 9401642. DOI: 10.1002/hsr2.786.

Improving heart failure care and guideline-directed medical therapy through proactive remote patient monitoring-home telehealth and pharmacy integration.

Lynch K, Ganz D, Saliba D, Chang D, de Peralta S BMJ Open Qual. 2022; 11(3).

PMID: 35902181 PMC: 9341192. DOI: 10.1136/bmjoq-2022-001901.

References

Day S, Altman D . Statistics notes: blinding in clinical trials and other studies. BMJ. 2000; 321(7259):504. PMC: 1118396. DOI: 10.1136/bmj.321.7259.504. View

Leung W, So W, Tong P, Chan N, Chan J . Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med. 2005; 118(12):1414. DOI: 10.1016/j.amjmed.2005.07.050. View

Robinson J, Conroy C, Wickemeyer W . A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol < or = 100 mg/dl. Am J Cardiol. 2000; 85(3):305-8. DOI: 10.1016/s0002-9149(99)00737-7. View

Guthrie R . The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001; 23(6):970-80. DOI: 10.1016/s0149-2918(01)80084-9. View

Muhlhauser I, Berger M . Patient education - evaluation of a complex intervention. Diabetologia. 2002; 45(12):1723-33. DOI: 10.1007/s00125-002-0987-2. View

Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348(5):383-93. DOI: 10.1056/NEJMoa021778. View

Vijan S, Hayward R . Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003; 138(7):593-602. DOI: 10.7326/0003-4819-138-7-200304010-00018. View

Discher C, Klein D, Pierce L, Levine A, Levine T . Heart failure disease management: impact on hospital care, length of stay, and reimbursement. Congest Heart Fail. 2003; 9(2):77-83. DOI: 10.1111/j.1527-5299.2003.01461.x. View

Grancelli H, Varini S, Ferrante D, Schwartzman R, Zambrano C, Soifer S . Randomized Trial of Telephone Intervention in Chronic Heart Failure (DIAL): study design and preliminary observations. J Card Fail. 2003; 9(3):172-9. DOI: 10.1054/jcaf.2003.33. View

10.

So W, Tong P, Ko G, Leung W, Chow C, Yeung V . Effects of protocol-driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes. Am J Manag Care. 2003; 9(9):606-15. View

11.

Grol R, Grimshaw J . From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003; 362(9391):1225-30. DOI: 10.1016/S0140-6736(03)14546-1. View

12.

Vijan S, Hayward R . Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med. 2004; 140(8):650-8. DOI: 10.7326/0003-4819-140-8-200404200-00013. View

13.

So W, Ozaki R, Chan N, Tong P, Ho C, Lam C . Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension. 2004; 44(3):294-9. DOI: 10.1161/01.HYP.0000137192.19577.c3. View

14.

Rudd P, Byyny R, Zachary V, LoVerde M, Titus C, Mitchell W . The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989; 46(2):169-76. DOI: 10.1038/clpt.1989.122. View

15.

Colley C, Lucas L . Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993; 8(5):278-83. DOI: 10.1007/BF02600099. View

16.

Smith C, Yawn B . Factors associated with appointment keeping in a family practice residency clinic. J Fam Pract. 1994; 38(1):25-9. View

17.

Prochaska J, Velicer W, Rossi J, Goldstein M, Marcus B, Rakowski W . Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994; 13(1):39-46. DOI: 10.1037//0278-6133.13.1.39. View

18.

Friedman R, Kazis L, Jette A, Smith M, Stollerman J, Torgerson J . A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996; 9(4 Pt 1):285-92. DOI: 10.1016/0895-7061(95)00353-3. View

19.

Haynes R, McKibbon K, Kanani R . Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996; 348(9024):383-6. DOI: 10.1016/s0140-6736(96)01073-2. View

20.

Hamilton W, Hopkins U . Survey on unclaimed prescriptions in a community pharmacy. J Am Pharm Assoc (Wash). 1997; NS37(3):341-5. DOI: 10.1016/s1086-5802(16)30220-0. View